EIDD-1931 Oral Capsules
Choose Cat's Body Weight
CureFIP™ EIDD-1931 delivers pure EIDD-1931, the active antiviral metabolite of molnupiravir, in a formulation designed exclusively for feline physiology. By using EIDD-1931 directly—rather than modifying human molnupiravir capsules—CureFIP™ EIDD-1931 provides a more precise, consistent, and veterinary-appropriate approach to FIP care.
Purpose-Built Feline Formulation
Each CureFIP™ EIDD-1931 capsule contains 15 mg of EIDD-1931, equivalent in activity to approximately 66 mg of molnupiravir (EIDD-2801).
This formulation is optimized for:
Feline metabolic rate
Gastrointestinal absorption profile
Reliable dose–response performance
The result is accurate, predictable antiviral activity with reduced variability compared to human-intended products.
Proven Antiviral Potency
Published research demonstrates that:
EIDD-1931 exhibits up to 10× greater in-vitro antiviral potency compared with molnupiravir (EIDD-2801).
EIDD-1931 demonstrates 7.3× higher potency than GS-441524 under similar test conditions.
This potency advantage enables therapeutic efficacy at lower milligram doses, supporting improved tolerability and rapid clinical response.
Reference:
Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity Against Enterovirus Infections In Vitro and In Vivo
https://www.mdpi.com/1999-4915/14/6/1142
Comprehensive Support Across FIP Presentations
CureFIP™ EIDD-1931 is formulated to support recovery across all major forms of FIP, including:
Wet FIP (effusive)
Dry FIP (non-effusive)
Mixed or transitional presentations
Additional formulation benefits:
Optimized for feline metabolism and tissue penetration
Highly consistent blood-level performance
Designed to support low relapse incidence when used according to veterinary guidance
Precision, Safety & Confidence in Every Dose
With CureFIP™ EIDD-1931, your cat receives an advanced, veterinary-engineered antiviral designed for dependable performance:
Scientifically grounded formulation
Consistent mg-per-kg dosing
No need to modify human medications
Backed by modern antiviral research
Dosage Instruction
Dosage Instructions
Administer one (1) capsule per 2.5 kg of body weight, given every 12 hours.
Dosing Examples
• Example 1: A 2.0 kg kitten diagnosed with the effusive (wet) form of FIP should receive one capsule every 12 hours.
• Example 2: A 4.6 kg adult cat diagnosed with the non-effusive (dry) form of FIP should receive two capsules every 12 hours.
Monitoring and Follow-Up
We strongly recommend that your cat receives a complete blood panel approximately every 30 days, in conjunction with ongoing evaluation by your primary veterinarian. Regular monitoring allows your veterinarian to assess clinical response and determine whether continued treatment, dose adjustment, or discontinuation is appropriate.
Product Description
Active Ingredient: EIDD-1931
Inactive Ingredient: Dibasic Calcium Phosphate, Magnesium Sterate
Form: Size #3 Capsules
Indications: Ideal for felines with effusive (wet) and non-effusive (dry) feline infectious peritonitis (FIP)
Specification: 60 capsules, each containing 15 mg of EIDD-1931
Dosage: 1 capsule every 12 hours for every 2.5 kg of body weight, preferably on an empty stomach.
If vomiting occurs within 30 minutes, administer another capsule.
Not Recommended Use:
• Ocular or neurological FIP cases.
• Cats not feeding or defecating normally
• Cats with a history of poor dietary absorption.
Length of Treatment: Up to 60 days or as recommended by a veterinarian.
Storage: Store in a dry, cool place away from sunlight.
Packaging:
Each pack contains 60 capsules in vacuum-sealed mylar bag.
For cats weighing up to 2.5kg package use 60 capsules every 30 days.
For cats weighing 2.5 to 5kg package use 120 capsules every 30 days.
For cats weighing above 5kg package contains 180 capsules every 30 days.
Expiration: 12 months
Shipping Info
Shipping Time:
2 days to major US Cities
3 ~ 4 days to US townships and Canada .
Shipping Condition:
Shipped under ambient temperature in individually packed, air sealed mylar bags.
Return and Refund Policy
To uphold the highest standards of pharmaceutical safety, quality, and product integrity, we are unable to accept returns or issue refunds once an order has been delivered. This ensures that every product that reaches our customers has been handled, stored, and managed according to strict quality control requirements.
If your order is damaged, defective, or lost in transit, we will provide a free replacement at no additional cost to you. Simply contact our support team with your order details, and we will resolve the issue promptly.
This policy protects the safety of all customers and ensures that every product dispensed remains uncompromised and fully compliant with pharmaceutical standards.